CRL
Charles River Laboratories International, Inc.
Stock
$290.19+3.36 (+1.17%)Close Oct 2, 2026
- Diluted EPS, 2025
- −$2.91
Diluted EPS
Diluted EPS by fiscal year
| Period | EPS | YoY |
|---|---|---|
| 2025 | −$2.91 | — |
| 2024 | $0.20 | −97.8% |
| 2023 | $9.22 | −2.7% |
| 2022 | $9.48 | +24.7% |
| 2021 | $7.60 | +5.6% |
| 2020 | $7.20 | +42.0% |
| 2019 | $5.07 | +9.7% |
| 2018 | $4.62 | +81.9% |
| 2017 | $2.54 | −21.4% |
| 2016 | $3.23 | +3.2% |
| 2015 | $3.13 | +17.7% |
| 2014 | $2.66 | +25.5% |
| 2013 | $2.12 | +5.5% |
| 2012 | $2.01 | −6.1% |
| 2011 | $2.14 | — |
| 2010 | −$5.38 | — |
| 2009 | $1.74 | — |
| 2008 | −$7.80 | — |